|
|
Value of plasma D-dimer,fibrinogen levels monitoring in non-small cell lung cancer patients in perioperative period |
JIANG Lvquan1,GAO Kunxiang2,ZHENG Jian1,CHEN Jian1,WU Hao1,and CHEN Linsong1 |
1.Department of Thoracic Surgery, Jiangsu Provincial Corps Hospital of Chinese People’s Armed Police Forces,Yangzhou 225003,China;2. Deparment of Thoracic Surgery, Tangdu Hospital,Fourth Military Medical University, Xi’an 710038,China |
|
|
Abstract Objective Bleeding or thrombotic diseases are easily to be found in non-small cell lung cancer(NSCLC) patients, because the equilibrium of their coagulation system might be disturbed due to tumor burden or surgical injury.In the study, we studied the value of plasma D-dimer and fibrinogen levels monitoring in patients with non-small cell lung cancer before and after surgery. Methods The plasma D-dimer and fibrinogen levels were measured in 254 patients with non-small cell lung cancer and 52 patients with benign lung tumor,and then we followed up to record the D-dimer and fibrinogen levels change in postoperative patients. Results The plasma levels of D-dimer and fibrinogen in non-small cell lung cancer patients were found to be significantly higher than those in patients with benign lung tumor (P<0.01).Significant differences in D-dimer and fibrinogen levels were found among different stages of non-small cell lung cancer (P<0.01),which suggested that coagulation and fibrinolysis dysfunction in patients with non-small cell lung cancer aggravated along with the progression of disease.The D-dimer and fibrinogen levels kept at a high level or rose suddenly after a transient decrease in 15 patients who had thrombotic diseases after operation. Conclusions Monitoring the plasma D-dimer and fibrinogen levels in patients with non-small cell lung cancer before and after operation helps find out those who have high risk of thrombotic diseases and preventing thrombtic disease after operation. It also helps us to strive for early prevention,early diagnosis,early treatment,nd to improve the prognosis of the patients.
|
Received: 18 December 2012
|
|
|
|
|
[1] |
陈万清,张思维,郑荣寿,等.中国肿瘤登记地区2007年肿瘤发病率和死亡分析[J].中国肿瘤,2011,20(3):162-169.
|
[1] |
陈万清,张思维,郑荣寿,等.中国肿瘤登记地区2007年肿瘤发病率和死亡分析[J].中国肿瘤,2011,20(3):162-169.
|
[2] |
Ettinger D S,Akerley W,Bepler G,et al.Non-small cell lung cancer[J].J Natl Compr Canc Netw,2010,8(7):740-801.
|
[2] |
Ettinger D S,Akerley W,Bepler G,et al.Non-small cell lung cancer[J].J Natl Compr Canc Netw,2010,8(7):740-801.
|
[3] |
徐澄澄,付向宁.肺癌与高血凝状态的研究进展[J].中华肿瘤防治杂志,2010,17(10):790-94.
|
[3] |
徐澄澄,付向宁.肺癌与高血凝状态的研究进展[J].中华肿瘤防治杂志,2010,17(10):790-94.
|
[4] |
Xlao B,Ma L L,Zhang S D,et al. Correlation between coagulation function,tumor stage and metastasis in patients with renal cell carcinoma:a retrospective study[J].Chin Med J Engl,2011,124(10):1205-1208.
|
[4] |
Xlao B,Ma L L,Zhang S D,et al. Correlation between coagulation function,tumor stage and metastasis in patients with renal cell carcinoma:a retrospective study[J].Chin Med J Engl,2011,124(10):1205-1208.
|
[5] |
李 珺,王 泳,张雪松,等.肺癌患者纤维蛋白原及D-二聚体与肿瘤分期、转移的关系[J].中华临床医师杂志,2011,5(21):6457-6459.
|
[5] |
李 珺,王 泳,张雪松,等.肺癌患者纤维蛋白原及D-二聚体与肿瘤分期、转移的关系[J].中华临床医师杂志,2011,5(21):6457-6459.
|
[6] |
Torbicki A,Perrieer A,Konstantinides S,et al.Guidelines on the diagnosis and management of acute pulmonary embolism:the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiolo-gY(ESC) [J].Eur Heart J,2008,29(11):2276-2315.
|
[6] |
Torbicki A,Perrieer A,Konstantinides S,et al.Guidelines on the diagnosis and management of acute pulmonary embolism:the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiolo-gY(ESC) [J].Eur Heart J,2008,29(11):2276-2315.
|
[7] |
张玉冲,高学新.D-二聚体检测在胸外科手术后肺栓塞诊断中的应用[J].泰山医学院学报,2005,26(6):560-561.
|
[7] |
张玉冲,高学新.D-二聚体检测在胸外科手术后肺栓塞诊断中的应用[J].泰山医学院学报,2005,26(6):560-561.
|
[8] |
王 敏,江铭磊,江 榕,等.血浆D-二聚体在卵巢癌患者围手术期监测中的应用价值[J].中国癌症杂志,2012,22(5):381-384.
|
[8] |
王 敏,江铭磊,江 榕,等.血浆D-二聚体在卵巢癌患者围手术期监测中的应用价值[J].中国癌症杂志,2012,22(5):381-384.
|
[9] |
门剑龙,任 静.D-二聚体临床应用及标准化分析进展[J].中华检验医学杂志,2010,33(8):793-797.
|
[9] |
门剑龙,任 静.D-二聚体临床应用及标准化分析进展[J].中华检验医学杂志,2010,33(8):793-797.
|
[10] |
Masatoshi O,Yoshitake A,Takashi O, el al.High preoperative plasma D-dimer level is associated with advanced tumor atage and short survival after curative resection in patients with colorectal cancer[J].Jpn J Clin Oncol,2011,31(8):388-394.
|
[10] |
Masatoshi O,Yoshitake A,Takashi O, el al.High preoperative plasma D-dimer level is associated with advanced tumor atage and short survival after curative resection in patients with colorectal cancer[J].Jpn J Clin Oncol,2011,31(8):388-394.
|
[11] |
刘亚峰,原永平.D-二聚体与肺癌临床分期之间关系的研究[J].中国现代医药杂志,2007,9(2):80-81.
|
[11] |
刘亚峰,原永平.D-二聚体与肺癌临床分期之间关系的研究[J].中国现代医药杂志,2007,9(2):80-81.
|
[12] |
陈伟良,镇 奋,吕英俊,等.下腔静脉滤器置入及动脉导管溶栓治疗下肢深静脉血栓68例[J].武警医学,2011,22(1):51-52.
|
[12] |
陈伟良,镇 奋,吕英俊,等.下腔静脉滤器置入及动脉导管溶栓治疗下肢深静脉血栓68例[J].武警医学,2011,22(1):51-52.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(8): 711-712. |
|
|
|
|